Projects funded by the NCN

Analysis and evaluation of the effectiveness of anorexic and safety properties for the new histamine H3 receptor ligands

Call: OPUS 12 , Panel: NZ7

Principal investigator: dr hab. Magdalena Kotańska

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Novel hybrid compounds derived from pyrrolidine-2,5-dione or imidazolidine-2,4-dione scaffold and their effect on centra...

Call: OPUS 13 , Panel: NZ7

Principal investigator: dr hab. Krzysztof Kamiński

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Pharmacokinetic and pharmacodynamic interactions of the ECG modifying drugs - key covariates analysis.

Call: SONATA 6 , Panel: NZ7

Principal investigator: dr Barbara Wiśniowska

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic param...

Call: OPUS 10 , Panel: NZ7

Principal investigator: prof. Anna Wesołowska

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Synthesis, physicochemical and pharmacological properties of new amide derivatives of 3,3-disubstituted pyrrolidine-2,5-...

Call: OPUS 6 , Panel: NZ7

Principal investigator: prof. Jolanta Obniska

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

The search of new substances with diversified protective properties in different types of animal seizure models among am...

Call: SONATA 3 , Panel: NZ7

Principal investigator: dr hab. Krzysztof Kamiński

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Neuroprotective role of the GPR39 receptor in the central nervous system. Its relationship to Alzheimer Disease.

Call: OPUS 10 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Młyniec

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny